Biogen Idec and Swedish Orphan Biovitrum receive opinion from EMA
9 May 2011 | By Biogen Idec
The EMA Pediatric Committee has adopted an opinion agreeing to the pediatric investigational plan...
List view / Grid view
News
Pfizer’s Prevnar 13® meets all study endpoints in two pivotal phase 3 trials in adults aged 50 and older
9 May 2011 | By Pfizer
Pfizer Inc. announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine...
Merck announces Hope Against Hepatitis C initiative to support fight against Hepatitis C Virus
9 May 2011 | By Merck
Aim is to increase awareness, prevention and diagnosis of HCV infection....
Cephalon presents positive results with NUVIGIL in largest shift work disorder trial ever conducted
6 May 2011 | By Cephalon Inc
Cephalon, Inc. presented positive results from a phase IV trial...
Abbott receives FDA approval to expand use of the RX ACCULINK® Carotid Stent System
6 May 2011 | By Abbott
Abbott announced that the FDA approved the RX ACCULINK® Carotid Stent System...
Novartis gains FDA approval for Afinitor®
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
Sigma® Life Science and King’s College London co-developing miRNA Target Identification Technology
5 May 2011 | By kdm communications limited
Exclusive license to develop and commercialize new technology...
Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
5 May 2011 | By The Scott Partnership
Novozymes Biopharma, unveiled its enhanced next-generation albumin technology...
The European Commission approves Pfizer’s Revatio® (sildenafil)
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
Small, smaller, Ministat!
5 May 2011 | By Peter Huber Kältemaschinenbau GmbH
Huber Ministats are the smallest cooling thermostats in the world! Despite their size Ministats have enough power...
Sanofi-aventis and Medicines for Malaria Venture join forces to develop innovative malaria drugs
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
Gilead extends its funding support for the Gilead Sciences Research Centre
5 May 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. has extended its funding support of the Gilead Sciences Research Centre at the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague...
ERT Announces Appointment of New President and CEO
4 May 2011 | By The Scott Partnership
ERT, has appointed Jeffrey S. Litwin, as its new President and Chief Executive Officer and as a member of the board...
Thermo Fisher Scientific announces upgrade program for NanoDrop Instruments
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new upgrade program that includes the donation of reconditioned Thermo Scientific NanoDrop 1000 spectrophotometers to academic institutions in developing countries.
FDA approves linagliptin tablets for the treatment of type 2 diabetes
3 May 2011 | By OgilvyHealthPR
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy…
